Professor @OHSUKnight, A team of motivated scientists studying microenvironmental regulation of pre-leukemic and leukemic cells
Portland, Oregon
Joined December 2019
- Tweets1.1K
- Following386
- Followers799
- Likes5.6K
Anupriya Agarwal Lab retweeted
Happy to help lead this study here at @OHSUKnight for our patients and families.
Excited to share that our low-dose Sirolimus study for Adults with RUNX1-FPD is now enrolling @OHSUNews. Thanks for partnership: @OHSUKnight, @CLachowiez, Dr. DiNardo, @RUNX1Research @AmericanCancer. Pl share with eligible individuals. https:/clinicaltrials.gov/study/NCT07844694
Anupriya Agarwal Lab retweeted
Since 2017, RRP has funded and co-funded more than 30 investigators at institutions across the world working to better understand RUNX1-FPD and prevent blood cancer.
None of it happens without community support. As we continue to fund the next generation of research, your donation helps keep this work moving forward.
100% of donations go directly to funding this research: runx1researchprogram.org/xDo…
Anupriya Agarwal Lab retweeted
Now enrolling: a pilot clinical trial at @UTMDAnderson evaluating low-dose sirolimus (rapamycin) in individuals with RUNX1-FPD.
The study’s primary objective is to assess safety and tolerability. The scientific rationale is based on whether mTORC1 pathway inhibition may support hematopoietic health and potentially reduce blood cancer risk in RUNX1-FPD.
Clinicians are encouraged to review and refer eligible patients here for more information: runx1researchprogram.org/xSi…
Anupriya Agarwal Lab retweeted
Paying peer reviewers led to faster first editorial decisions — an average of 5.5 working days, down from nearly 38 for unpaid reviews.
The review quality, as judged by handling editors on the basis of helpfulness in making an editorial decision, went up.
1/
Anupriya Agarwal Lab retweeted
At @theNCI, our mission is simple: reduce the burden of cancer.
That means moving faster—from discovery to patient impact—and doing it together.
Follow along as we work to drive the next generation of breakthroughs.
Anupriya Agarwal Lab retweeted
We are actively recruiting a postdoctoral fellow to join our lab @jacksonlab! 😎 Details and link to apply: thejacksonlaboratory.wd503.m…
Anupriya Agarwal Lab retweeted
📣 Save the Date | Oregon Drug Discovery Symposium (ODDS) 2026
The symposium takes place April 8–9, 2026, and will feature scientific talks, discussions, and a poster session, providing a forum for knowledge exchange across disciplines.
Register: bit.ly/4qbMRU0
ALT Drs. Sanjay Malhotra (L) and Shivaani Kummar (R) pose for an image while wearing their white research lab coats inside an OHSU facility.
Anupriya Agarwal Lab retweeted
Join us for Knight School to learn about the latest advances in cancer early detection, including clinical trials and early detection blood tests.
📍 Knight Cancer Research Building
⌚️ 5:30 pm
🗓️ March 31
🎟️ FREE
bit.ly/40TzeOI
Anupriya Agarwal Lab retweeted
The National Cancer Advisory Board meets March 16–17. NCAB helps shape NCI’s research priorities and funding decisions, guiding the direction of our nation’s cancer efforts. I encourage you to join the open session via videocast and stay engaged.
cancer.gov/about-nci/advisor…
#NCAB
Anupriya Agarwal Lab retweeted
New preprint: teaching single-cell foundation models to learn from perturbations in collaboration with @madduri & @RUNX1Research supported by @cziscience.
Closing the loop identified a target for RUNX1-FPD now in Ph2 trials
🔗biorxiv.org/content/10.1101/…
🧵by @yash_persh👇
Anupriya Agarwal Lab retweeted
A new preprint led by @AlexBickMDPhD, @madduri, and @yash_pershad, with co-authors including @LabAgarwal and RRP’s @EricsonKatrin, uses a closed-loop #AI system to identify and validate therapeutic targets for RUNX1-FPD.
One of these targets, mTOR, supports earlier findings by Dr. Agarwal that led to the ongoing sirolimus clinical trial for RUNX1-FPD patients led by Dr. Courtney DiNardo at @MDAndersonNews: runx1-fpd.org/patient-resear…
A powerful example of how science, AI, and #patientadvocacy can come together to advance clinical progress!
New preprint: teaching single-cell foundation models to learn from perturbations in collaboration with @madduri & @RUNX1Research supported by @cziscience.
Closing the loop identified a target for RUNX1-FPD now in Ph2 trials
🔗biorxiv.org/content/10.1101/…
🧵by @yash_persh👇
Anupriya Agarwal Lab retweeted
If you’re at the #ASH24 conference, stop by and see us at booth 3456! 👋
ALT Person smiling at a booth for the OHSU Knight Cancer Institute at a career event, featuring a banner with cityscape background and the text 'Let your career SOAR at the OHSU Knight Cancer Institute.'
Anupriya Agarwal Lab retweeted
Join our 2nd sirolimus pilot study webinar on August 9th! Dr. Courtney DiNardo (@MDAndersonNews) will discuss study objectives and eligibility, and Dr. @LabAgarwal will share the lab research that indicated sirolimus should be tested in #RUNX1FPD patients. bit.ly/tRRPSirolimusAug
Anupriya Agarwal Lab retweeted
Dr. @coussens_lisa's work “led a shift in the way we think of cancer, from a bunch of cells in isolation to considering how the surrounding microenvironment around the tumors can be exploited to develop better anti-cancer therapies.”
#WomensHistoryMonth: spr.ly/6016kJt1I
Anupriya Agarwal Lab retweeted
Exciting News! RRP is in the midst of our annual fundraising campaign, and this year, we've received a fantastic opportunity: a matching grant from a generous anonymous donor!
𝗙𝗿𝗼𝗺 𝗻𝗼𝘄 𝘂𝗻𝘁𝗶𝗹 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟯𝟭, 𝟮𝟬𝟮𝟯, 𝗥𝗥𝗣 𝘄𝗶𝗹𝗹 𝗺𝗮𝘁𝗰𝗵 𝘆𝗼𝘂𝗿 𝗱𝗼𝗻𝗮𝘁𝗶𝗼𝗻 𝗱𝗼𝗹𝗹𝗮𝗿 𝗳𝗼𝗿 𝗱𝗼𝗹𝗹𝗮𝗿 𝘂𝗽 𝘁𝗼 $𝟱𝟬,𝟬𝟬𝟬! This is a powerful chance to double the impact of your contribution, so please click here to give a gift today: runx1-fpd.org/donate
#CancerResearch #runx1 #HolidayGiving
Anupriya Agarwal Lab retweeted
Academic research is dying. Research institutions are now merely training grounds for biotech/pharma personnel. We need advocacy, political pressure & bold solutions to keep young scientists with us. That is why we need voices like @rosslevinemd active!
statnews.com/2023/11/15/life…
Anupriya Agarwal Lab retweeted
Happy #Diwali to all those who celebrate ✨
@NASAHubble captured a celestial festival of lights – a globular cluster – 30,000 light-years away from Earth, near the dense and dusty center of our own Milky Way galaxy.
ALT A globular cluster appears near the center of the frame, with many yellow stars huddled together. Blue and yellow stars dot the blackness of space, surrounding the image’s center. Credit: ESA/Hubble & NASA, F. Ferraro
Anupriya Agarwal Lab retweeted
Any thoughts from leukemia Twitter to help this little girl?
Anupriya Agarwal Lab retweeted
"School was not easy for me."
Carol Greider achieved success in molecular biology in the same way she overcame dyslexia as a child: with persistence and creativity. Greider is one of many Nobel Prize laureates that have dyslexia.
#IWD2023
ALT Carol Greider in white tie standing during the Nobel Prize ceremony.